Evidence map›Paper›PMID 39337176›Full record

ArticleHealthcare (Basel, Switzerland)2024

Second Victims in Industries beyond Healthcare: A Scoping Review.

Andrea Conti, Alicia Sánchez-García, Daniele Ceriotti, Marta De Vito, Marco Farsoni, Bruno Tamburini, Sophia Russotto, Reinhard Strametz, Kris Vanhaecht, Deborah Seys and 2 more

Abstract readScoping Review
In one paragraph

Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrea ContiDepartment of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0002-0021-117X
Alicia Sánchez-GarcíaDepartment of Health Psychology, Miguel Hernandez University, 03202 Elche, Spain.ORCID 0009-0001-7943-3030
Daniele CeriottiDepartment of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0002-0270-4058
Marta De VitoDepartment of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy.
Marco FarsoniDepartment of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy.
Bruno TamburiniDepartment of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy.
Sophia RussottoDepartment of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy.
Reinhard StrametzWiesabden Institute for Healthcare Economics and Patient Safety, RheinMain UAS, 65197 Wiesbaden, Germany.ORCID 0000-0002-9920-8674
Kris VanhaechtLeuven Institute for Healthcare Policy, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0001-5636-4792
Deborah SeysLeuven Institute for Healthcare Policy, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-4966-3879
José Joaquín MiraDepartment of Health Psychology, Miguel Hernandez University, 03202 Elche, Spain.ORCID 0000-0001-6497-083X
Massimiliano PanellaDepartment of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0003-1880-7198

Funding

European Cooperation in Science and Technology CA19113
6 · The paper itself

Abstract

The second victim phenomenon (SVP) refers to workers negatively impacted by involvement in unanticipated adverse events or errors. While this phenomenon has been extensively studied in healthcare since its acknowledgment over 20 years ago, its presence and management in other high-risk industries have remained unclear. We conducted a scoping review aiming to map the SVP in non-healthcare industries, as well as to explore the available interventions or support programs addressed to help second victims (SVs). A total of 5818 unique records were identified and, after the screening process, 18 studies from eight sectors were included. All industries acknowledged the existence of the SVP, though many did not use a specific term for defining the SV. Similarities in psychological and emotional consequences were found across sectors. Support strategies varied, with the aviation sector implementing the most comprehensive programs. Self-care and peer support were the most reported interventions, while structured clinical support was not mentioned in any industry. Our review highlighted a lack of standardized terminology and industry-specific, evidence-based support interventions for the SVP outside of healthcare. Healthcare appears to be at the forefront of formally recognizing and addressing the SVP, despite traditionally learning from other high-reliability industries in safety practices. This presents opportunities for reciprocal learning and knowledge transfer between healthcare and other high-risk sectors.

Indexed as

cross-industry learningerror managementjust culturepeer supportsafetysecond victim phenomenon

Identifiers

PMID39337176
PMCPMC11431445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.